AVBP
ArriVent BioPharma, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$31.02
−0.03%Aug 12, 2026, 20:01 UTC
ArriVent BioPharma reported its financial results for the second quarter ended June 30, 2026.
Source:
NASDAQ · Healthcare · Biotechnology · US
Aug 12, 2026, 20:01 UTC